Drugs / PROTIRELIN

Trials 4

19931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 22 trials
Phase 2 NCT00790296 Dec 2006 → Feb 2010 myalgic encephalomeyelitis/chronic fatigue syndrome UConn Health Terminated No outcome recorded
Phase 2 NCT00054756 Feb 2003 → Sep 2014 pituitary gland disorder, thyroid gland disorder National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Completed No outcome recorded
Phase 31 trial
Phase 3 NCT00004778 Aug 1993 → ? newborn respiratory distress syndrome National Center for Research Resources (NCRR) Completed No outcome recorded
Phase not applicable1 trial
— NCT00004840 May → Jun 1998 respiratory distress syndrome in premature infants Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Completed No outcome recorded
Comparator or background therapy1 trial
— NCT02399475 Background Jan 2015 → Sep 2019 hypothyroidism University of Pennsylvania Completed No outcome recorded

Evidence & citations 25 cited values

Every value below carries the sentence it was read from. 6 sources stand behind the page.

FieldValueCited text
Known as PROTIRELIN ChEMBL registry synonym — accepted as the source's own label CHEMBL1472 ↗
Known as 5-oxo-pro-his-pro-nh2 ChEMBL registry synonym — accepted as the source's own label CHEMBL1472 ↗
Known as A-38579 ChEMBL registry synonym — accepted as the source's own label CHEMBL1472 ↗
Known as ABBOTT-38579 ChEMBL registry synonym — accepted as the source's own label CHEMBL1472 ↗
Known as Lopremone ChEMBL registry synonym — accepted as the source's own label CHEMBL1472 ↗
Known as NSC-760113 ChEMBL registry synonym — accepted as the source's own label CHEMBL1472 ↗
Known as Protirelin tartrate ChEMBL registry synonym — accepted as the source's own label CHEMBL1472 ↗
Known as Protirelin, synthetic ChEMBL registry synonym — accepted as the source's own label CHEMBL1472 ↗
Known as Protirelina ChEMBL registry synonym — accepted as the source's own label CHEMBL1472 ↗
Known as Protireline ChEMBL registry synonym — accepted as the source's own label CHEMBL1472 ↗
Known as Relefact trh ChEMBL registry synonym — accepted as the source's own label CHEMBL1472 ↗
Known as SYNTHETIC TRH ChEMBL registry synonym — accepted as the source's own label CHEMBL1472 ↗
Known as Thypinone ChEMBL registry synonym — accepted as the source's own label CHEMBL1472 ↗
Known as Thyrel trh ChEMBL registry synonym — accepted as the source's own label CHEMBL1472 ↗
Known as Thyroid releasing hormone ChEMBL registry synonym — accepted as the source's own label CHEMBL1472 ↗
Known as Thyroliberin ChEMBL registry synonym — accepted as the source's own label CHEMBL1472 ↗
Known as Thyrotropin Releasing Hormone “TRH (Thyrotropin Releasing Hormone)” NCT00054756 ↗
4

NCT00790296 ↗

NCT02399475 ↗

NCT00004778 ↗

NCT00004840 ↗

Known as Thyrotropin-releasing factor ChEMBL registry synonym — accepted as the source's own label CHEMBL1472 ↗
Known as TRH “intravenous thyrotropin-releasing hormone (TRH)” NCT00004778 ↗
2

“Thyrotropin releasing hormone (TRH)” NCT00790296 ↗

NCT00054756 ↗

Known as Trh-cambridge ChEMBL registry synonym — accepted as the source's own label CHEMBL1472 ↗
Action Activate “Thyrotropin-releasing hormone receptor agonist” CHEMBL1472 ↗
Modality Peptide “TRH is a neuropeptide used in the diagnostic evaluation of patients with dysfunction of the hypothalamic-pituitary-thyroid (HPT) axis.” NCT00054756 ↗
Modality Protein / enzyme biologic — CHEMBL1472 ↗
Route Intravenous “intravenous thyrotropin-releasing hormone (TRH)” NCT00004778 ↗
Target TRHR “Thyrotropin-releasing hormone receptor agonist” CHEMBL1472 ↗